Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | ARG2 | P78540 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18241009 | 1.00 | MAOB (0.54) | MAOBCA1CA2ARG2KCNH2 | |
| SCHEMBL7980743 | 0.77 | MAOB (0.61) | MAOBCA1CA2ARG2KCNH2 | |
| SCHEMBL7980741 | 0.77 | MAOB (0.61) | MAOBCA1CA2ARG2KCNH2 | |
| SCHEMBL6668054 | 0.73 | MAOB (0.56) | MAOBCA1CA2ARG2KCNH2 | |
| SCHEMBL107005 | 0.72 | MAOB (0.61) | MAOBCA1CA2ARG2KCNH2 | |
| SCHEMBL107006 | 0.72 | MAOB (0.61) | MAOBCA1CA2ARG2KCNH2 | |
| SCHEMBL1524697 | 0.72 | MAOB (1.00) | MAOBCA1CA2ARG2KCNH2 | |
| SCHEMBL155055 | 0.72 | MAOB (1.00) | MAOBCA1CA2ARG2KCNH2 | |
| SCHEMBL155054 | 0.72 | MAOB (1.00) | MAOBCA1CA2ARG2KCNH2 | |
| SCHEMBL107789 | 0.71 | MAOB (0.65) | MAOBCA1CA2ARG2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2044001-B1 | PROCESS FOR PREPARATION OF 3-(2-HYDROXY-5-SUBSTITUTED PHENYL)-N-ALKYL-3-PHENYLPROPYLAMINES | LEK PHARMACEUTICALS (SI) | 2016-11-23 | — | — | EP | disclosed |
| US-20110306792-A1 | PROCESS FOR PREPARING TOLTERODINE AND THE L-TARTRATE THEREOF | 2Y-CHEM, LTD. (CN) | 2011-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306792-A1 | PROCESS FOR PREPARING TOLTERODINE AND THE L-TARTRATE THEREOF | ACHE, QDPR, DDC | MAOB 11/4885CA1 640/4885CA2 1146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.